“All pillars converge on a single storyline: Tesla + SpaceX will co-develop “Terafab” in Austin to manufacture advanced AI/robotics chips, starting with an AGI-oriented CPU. With no material dissent between Machine and Mechanics, the initiative’s chief risk is execution, not narrative conflict. Expect site preparation and early tool orders within 12-24 months and first limited-run wafers 3-5 years out, provided capital and regulatory milestones are met.”